Increased expression of P-selectin in patients with chronic atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 11 II, 2000, Pages 1872-1875

  Goette, Andreas ^a   Ittenson, Annelore ^b   Hoffmanns, Philipp ^a   Reek, Sven ^a   Hartung, Wolfgang ^a   Klein, Helmut ^a   Ansorge, Siegfried ^b   Geller, J Christoph ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b Inst of Exp Internal Medicine   (Germany)

Author keywords

ADP; Atrial fibrillation; Clopidogrel; Embolism; P selectin; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR AFFECTING AGENT; CLOPIDOGREL; PADGEM PROTEIN;

ADULT; ANTIGEN BINDING; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONFERENCE PAPER; EMBOLISM; FEMALE; FLOW CYTOMETRY; HEART ATRIUM FIBRILLATION; HUMAN; MALE; RISK FACTOR; SINUS RHYTHM; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM;

ADENOSINE DIPHOSPHATE; ATRIAL FIBRILLATION; BLOOD PLATELETS; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; HEART ATRIA; HEART RATE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PROTEINS; RECEPTORS, THROMBIN;

EID: 0033675582     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb07041.x     Document Type: Article

References (18)

1. Characteristics and prognosis of lone atrial fibrillation: 30 years follow-up in the Framingham Study
2. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke
3. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate elevated levels of intravascular thrombogenesis
4. Fibrin D-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low dose warfarin and aspirin
5. Increased intracardiovascular clotting in patients with chronic atrial fibrillation
6. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation
7. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation and cardiomyopathy
8. Procoagulatory effect of heavy exercise in patients with chronic atrial fibrillation
9. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils
10. Specific activation of platelets by surface-adsorbed plasma proteins
11. Novel antiplatelet therapies for treatment of patients with ischemic heart disease: Inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor
12. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation. Role of nitric oxide
13. Platelet activation by polymorphonuclear leukocytes: Role of cathepsin G and P-selectin
14. Low-dose aspirin does not lower in vivo platelet activation in healthy smokers
15. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation
16. A randomized blinded trial of clopidogrel vs. aspirin in patients at risk of ischemic events (CAPRIE)
17. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets: Role of protein kinase C
18. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits